The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN

Jerry L. Spivak, Alison R. Moliterno

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN'. Together they form a unique fingerprint.

Medicine & Life Sciences